Resources
About Us
Home Report
Store
Pharmaceutical Quality Management Systems Market
Pharmaceutical Quality Management Systems Market Size, Share, Forecast, & Trends Analysis by Solution Type (Deviation, CAPA, Audit, Risk & Compliance, Inspection, Change, Training) Deployment Mode (Cloud, On-premise) End User - Global Forecast to 2031
Report ID:MRHC - 104714 Pages: 215 Jul-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 48 HoursPharmaceutical Quality Management Systems Market Size & Forecast
The Pharmaceutical Quality Management Systems Market is expected to reach $4.59 billion by 2031, at a CAGR of 15.6% from 2024 to 2031. A pharmaceutical quality management system comprises procedures, processes, and policies aimed at ensuring high product quality in pharmaceutical manufacturing. These systems are tailored to meet the specific needs of the company and comply with regulatory standards. Regulatory requirements pertaining to product quality assist pharmaceutical companies in managing risks, enhancing customer satisfaction, and optimizing the quality control process. Pharmaceutical quality management systems enable document management, change control, training management, audit management, and deviation management.
Rising drug manufacturing costs, stringent regulatory standards for pharmaceutical production, rapid growth of the pharmaceutical industry, and the advantages of software-based quality management systems drive the growth of this market. However, the high costs of deploying pharmaceutical quality management systems restrain the growth of this market.
The increasing demand for generic drugs & biopharmaceuticals and the rising preference for platform-as-a-service solutions among pharmaceutical companies are expected to create market growth opportunities. However, security concerns associated with on-cloud deployments pose a significant challenge to the market’s growth.
Pharmaceutical Quality Management Systems Market Growth Drivers
Stringent Regulatory Standards for Pharmaceutical Production
Pharmaceutical products directly impact consumer health and well-being, making them subject to rigorous regulations. Manufacturers must adhere to strict safety and quality standards to bring their products to market. With the pharma sector expanding rapidly, companies are prioritizing compliance with regulations and investing in research and development to deliver superior products and maintain competitiveness. Many companies based in developing countries like India and China export to the U.S., where the FDA regulates products. To ensure product safety, the FDA conducts inspections of facilities and procedures of all pharmaceutical manufacturers, both domestic and international, that sell products in the U.S. Therefore, these companies must be FDA registered and comply with current good manufacturing practices (cGMP).
Additionally, manufacturers must adhere to guidelines such as ICH Guideline Q10, 21 CFR Part 211, and International Organization for Standardization (ISO) guidelines to produce and market their products. The rising regulatory requirements and expanding international markets have increased the demand for quality management systems among pharmaceutical manufacturers.
Click here to: Get Free Sample Pages of this Report
Advantages of Software-based Quality Management Systems
Manufacturers in the pharmaceutical industry encounter challenges due to evolving regulations, shifting market demands, and supply chain disruptions. Traditional systems often create gaps between quality management and manufacturing, resulting in difficulties in adapting to regulatory changes and delays in bringing drugs to market.
The adoption of software-based quality management systems addresses these challenges by enhancing product quality and ensuring patient safety. Pharmaceutical QMS software enables companies to comply with evolving global regulatory landscapes. As global trials and cross-border drug launches become more prevalent, this software facilitates regulatory compliance in each region, thereby reducing the risk of drug failures and accelerating time-to-market.
In addition to regulatory compliance, pharmaceutical QMS software offers streamlined operations, robust risk management and mitigation, enhanced consumer confidence, improved supply chain efficiency, increased process efficiency, and minimized drug wastage.
Pharmaceutical Quality Management Systems Market Trends
Integration of Artificial Intelligence Into Quality Management Systems
The integration of Artificial Intelligence (AI) into quality management systems offers numerous benefits. It enables the accurate and swift analysis of vast amounts of data, which can be a challenge if done manually. AI-powered systems enable efficient analyses, leading to improved decision-making, faster problem-solving, and enhanced quality control. Regulatory compliance is critical in the pharmaceutical industry, and AI integration into QMS can assist companies in automating compliance operations and providing real-time alerts when issues arise. AI can also automatically update QMS in response to legislative changes, ensuring compliance.
Artificial intelligence can analyze data from quality management systems to identify potential compliance issues early on. Major industry players are increasingly adopting AI-based pharmaceutical QMS solutions. For instance, in April 2023, Dot Compliance (U.S.) launched an AI-powered electronic quality management system designed for the life sciences sector. This system incorporates proprietary algorithms and utilizes ChatGPT to enhance compliance efforts within pharmaceutical organizations.
Pharmaceutical Quality Management Systems Market Opportunities
Increasing Demand for Generic Drugs & Biopharmaceuticals
The adoption of biopharmaceuticals is outpacing that of conventional synthetic drugs due to their benefits, including specific molecule targetting, low side effects, and high activity and specificity. Biopharmaceuticals are increasingly utilized in the treatment of immune-mediated inflammatory diseases (IMIDs) such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and cancer.
Quality management systems play a crucial role in the biopharmaceutical industry by ensuring standardized and high-quality products. These systems enable biopharmaceutical firms to consistently adhere to quality standards, comply with regulations, and continuously improve organizational processes. Quality management systems enable pharmaceutical and biopharmaceutical companies to enhance overall customer satisfaction, minimize the risk of product recalls, and improve product quality.
Pharmaceutical Quality Management Systems Market Analysis: Key Findings
By Solution Type: In 2024, the Non-conformance/Deviation Management Segment to Dominate the Pharmaceutical Quality Management Systems Market
Based on solution type, the pharmaceutical quality management systems market is segmented into non-conformance/deviation management, document management, CAPA management, risk & compliance, inspection management, audit management, suppliers & materials management, training management, change management, and other solution types. In 2024, the non-conformance/deviation management segment is expected to account for the largest share of 18.1% of the pharmaceutical quality management systems market. This segment’s large market share can be attributed to the growing adoption of non-conformance/deviation management to mitigate risks related to inadequate control over quality management systems, thereby enhancing efficiency across all business operations. Additionally, non-conformance management aids pharmaceutical manufacturers in detecting process and product defects early and anticipating potential future issues.
However, the CAPA management segment is projected to witness the highest growth rate of 17.3% during the forecast period of 2024–2031. This segment’s growth can be attributed to the increasing demand for Corrective and Preventive Action (CAPA) management in the pharmaceutical industry, driven by the need to ensure product quality, patient safety, and regulatory compliance. CAPA management is essential for identifying and addressing issues that could pose risks to patient safety, encompassing concerns related to product quality, manufacturing processes, labeling, and packaging.
By Deployment Mode: In 2024, the Non-conformance/Deviation Management Segment to Dominate the Pharmaceutical Quality Management Systems Market
Based on deployment mode, the pharmaceutical quality management systems market is segmented into cloud/web-based and on-premise. In 2024, the cloud/web-based segment is expected to account for the largest share of 79.4% of the pharmaceutical quality management systems market. The large market share of this segment is attributed to the benefits offered by cloud/web-based deployments, such as cost-effectiveness, real-time analysis capabilities, easy access to data, internal and external data sharing, flexibility, and scalability.
Cloud/web-based models are gaining rapid popularity in the pharmaceutical quality management systems market. These systems eliminate the need for hardware installation and maintenance costs, as well as the requirement for in-house IT maintenance and support teams. Therefore, the cost-effectiveness of cloud-based deployment makes it a viable option, even for small and medium-sized research laboratories.
By End User: In 2024, the Pharmaceutical and Biotechnology Companies Segment to Dominate the Pharmaceutical Quality Management Systems Market
Based on end user, the pharmaceutical quality management systems market is segmented into pharmaceutical and biotechnology companies, contract research organizations (CROS)/ contract development manufacturing organizations (CDMOs), and research laboratories. In 2024, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the pharmaceutical quality management systems market. This segment’s large market share can be attributed to frequent changes in manufacturing processes, stringent regulatory requirements, the growing need to increase production capacity, and the rising costs of drug manufacturing.
The pharmaceutical and biopharmaceutical sectors have witnessed significant growth in recent years due to the increasing demand for pharmaceutical products, growing adoption of single-use products, growing incidences and prevalence of various chronic diseases, and rising need to address unmet medical requirements for rare and chronic diseases. Additionally, governments of various countries are taking initiatives by making investments and providing grants and funds to pharmaceutical and biotechnology companies for the manufacture and R&D of biopharmaceuticals. For instance, in November 2021, Medical Research Agency (Poland) announced government funding of USD 73.3 million (PLN 300 million) for producing vaccines based on mRNA technology in Poland.
Geographical Analysis
In 2024, North America to Dominate the Market
In 2024, North America is expected to account for the largest share of the 38.4% of pharmaceutical quality management systems market. North America’s large market share can be attributed to the increasing use of advanced digital tools approved by regulatory authorities in the region’s pharmaceutical sector to improve overall development & manufacturing outcomes and the presence of major market players in the region. Additionally, the strong financial capabilities of small and mid-sized organizations drive the adoption of quality management systems in the region.
However, the market in Asia-Pacific is projected to register the highest CAGR of 16.8% during the forecast period. The growth of this regional market is driven by the large population base and government initiatives aimed at enhancing healthcare facilities and services in the region. Additionally, these countries have long been recognized as low-cost destinations for pharmaceutical manufacturing. As a result, major international companies are expanding their operations there to leverage these cost advantages and tap into the growing market opportunities in Asia-Pacific.
Pharmaceutical Quality Management Systems Market: Key Companies
The report offers a competitive landscape based on an extensive assessment of the leading players’ product portfolios and geographic presence and the key growth strategies adopted by them over the past few years. The key players profiled in the pharmaceutical quality management systems market are Honeywell International Inc. (U.S.), IQVIA Holdings Inc. (U.S.), ANTARES VISION S.p.A (Italy), Dassault Systèmes SE (France), EtQ Management Consultants, Inc. (U.S.), Ideagen PLC (U.K.), Körber AG (Germany), LogicGate, Inc. (U.S.), ComplianceQuest, Inc (U.S.), AssurX, Inc. (U.S.), and AXSource Consulting, Inc. (U.S.).
Pharmaceutical Quality Management Systems Market Overview: Latest Developments from Key Industry Players
-
In July 2023, Ideagen (U.K.) enhanced its internal audit and risk management solutions with the addition of enterprise risk management and internal audit capabilities.
-
In April 2023, ANTARES Vision (Italy) acquired Smart Point Technologies Ltd. (India) through its subsidiary rfXcel. Smart Point, a software development company, will significantly bolster ANTARES Vision's presence in the pharmaceutical Track & Trace sector.
- In February 2023, LogicGate (U.S.) partnered with Climb Channel Solutions (U.S.), an international specialty technology distributor and a subsidiary of Climb Global Solutions, Inc. (U.S.). This partnership was aimed at expanding the company’s presence in Europe, the Middle East, and Africa.
Pharmaceutical Quality Management Systems Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
215 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
15.6% |
|
Estimated Market Size (Value) |
$4.59 billion by 2031 |
|
Segments Covered |
By Solution Type
By Deployment Mode
By End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Ireland, Belgium, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, Singapore, Malaysia, Philippines, Vietnam, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa |
|
Key Companies |
The key players profiled in the pharmaceutical quality management systems market are Honeywell International Inc. (U.S.), IQVIA Holdings Inc. (U.S.), ANTARES VISION S.p.A (Italy), Dassault Systèmes SE (France), EtQ Management Consultants, Inc. (U.S.), Ideagen PLC (U.K.), Körber AG (Germany), LogicGate, Inc. (U.S.), ComplianceQuest, Inc (U.S.), AssurX, Inc. (U.S.), and AXSource Consulting, Inc. (U.S.). |
Key questions answered in the pharmaceutical quality management systems market report:
The pharmaceutical quality management systems market report covers market sizes & forecasts for solution types. The pharmaceutical quality management systems market study includes the value analysis of various segments and subsegments of the pharmaceutical quality management systems market at the country & regional level. The report also provides insights on factors impacting market growth, regulatory analysis, pricing analysis, and case studies.
The pharmaceutical quality management systems market is projected to reach $4.59 billion by 2031, at a CAGR of 15.6% from 2024 to 2031.
The non-conformance/deviation management segment is expected to account for the largest share of the pharmaceutical quality management systems market in 2024. The large market share of this segment is attributed to the increasing importance of deviations and non-conformance from a regulatory point of view. Process deviation and non-conformance records are critical and can affect the product approval for manufacturing or sale. Thus, many pharmaceutical players work with quality management systems (QMS) to comply with regulatory rules and avoid deviations and non-conformance.
The cloud/web-based segment is estimated to account for the largest share of the pharmaceutical quality management systems market in 2024. The large market share of this segment is attributed to the benefits offered by cloud/web-based deployments, such as cost-effectiveness, real-time analysis capabilities, easy access to data, internal and external data sharing, flexibility, and scalability
Rising drug manufacturing costs, stringent regulatory standards for pharmaceutical production, rapid growth of the pharmaceutical industry, and the advantages of software-based quality management systems drive the growth of this market.
Furthermore, the increasing demand for generic drugs & biopharmaceuticals and the rising preference for platform-as-a-service solutions among pharmaceutical companies are expected to create market growth opportunities.
The key players operating in the pharmaceutical quality management systems market are Honeywell International Inc. (U.S.), IQVIA Holdings Inc. (U.S.), ANTARES VISION S.p.A (Italy), Dassault Systèmes SE (France), EtQ Management Consultants, Inc. (U.S.), Ideagen PLC (U.K.), Körber AG (Germany), LogicGate, Inc. (U.S.), ComplianceQuest, Inc (U.S.), AssurX, Inc. (U.S.), and AXSource Consulting, Inc. (U.S.).
Emerging economies in Asia-Pacific, including China and India, are expected to offer growth opportunities for the players in this market. Government aimed at enhancing domestic manufacturing, an established pharmaceutical market, increasing R&D expenditures by pharmaceutical and biopharmaceutical companies, and favorable regulatory policies are the key factors driving the growth of the pharmaceutical quality management systems market in these nations.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for this Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Market Dynamics
4.2.1.1. Stringent Regulatory Standards for Pharmaceutical Production Driving the Adoption of Pharmaceutical Quality Management Systems
4.2.1.2. High Costs of Deploying Pharmaceutical Quality Management Systems Limiting their Adoption
4.2.1.3. Increasing Demand for Generic Drugs & Biopharmaceuticals Generating Growth Opportunities for Market Players
4.2.1.4. Security Concerns Associated with On-cloud Deployments Impacting the Implementation of Pharmaceutical QMS
4.2.2. Factor Analysis
4.3. Trends
4.3.1. Integration of Artificial Intelligence & Machine Learning into Pharmaceutical Quality Management Systems
4.3.2. Increasing Inclination Toward Personalized Medicine
4.4. Pharmaceutical Quality Management Systems Market: Regulatory Analysis
4.4.1. Overview
4.4.2. International Organization for Standardization (ISO)
4.4.3. Pharmaceutical Inspection Co-Operation Scheme (PIC/S)
4.4.4. ICH Guideline Q10
4.4.5. Current Good Manufacturing Practice (cGMP)
4.5. Pricing Analysis
4.6. Case Studies
5. Pharmaceutical Quality Management Systems Market Assessment—by Solution Type
5.1. Overview
5.2. Non-Conformance/Deviation Management
5.3. Document Management
5.4. CAPA Management
5.5. Risk & Compliance Management
5.6. Inspection Management
5.7. Audit Management
5.8. Suppliers & Materials Management
5.9. Training Management
5.10. Change Management
5.11. Other Solution Types
6. Pharmaceutical Quality Management Systems Market Assessment—by Deployment Mode
6.1. Overview
6.2. Cloud/Web-based
6.3. On-premise
7. Pharmaceutical Quality Management Systems Market Assessment—by End User
7.1. Overview
7.2. Pharmaceutical And Biotechnology Companies
7.3. Contract Development and Manufacturing Organization/Contract Research Organization
7.4. Research Laboratories
8. Pharmaceutical Quality Management Systems Market Assessment—by Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Ireland
8.3.7. Belgium
8.3.8. Netherlands
8.3.9. Rest of Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Singapore
8.4.5. Malaysia
8.4.6. Philippines
8.4.7. Vietnam
8.4.8. Rest of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Players Ranking (2023)
10. Company Profiles
10.1. Honeywell International Inc.
10.2. IQVIA Holdings Inc.
10.3. Dassault Systèmes SE
10.4. Körber AG
10.5. ANTARES VISION S.p.A.
10.6. EtQ Management Consultants Inc. (A Subsidiary of Hexagon AB)
10.7. Ideagen PLC (A Subsidiary of Rainforest Bidco Limited)
10.8. AssurX, Inc.
10.9. AXSource Consulting, Inc.
10.10. ComplianceQuest, Inc.
10.11. LogicGate, Inc.
10.12. MasterControl Solutions Inc.
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Recent Biopharmaceutical Plant Capacity Expansions
Table 2 Overview of Product Lifecycle Stages
Table 3 Overview of Standards and Compliance Guidelines Related to Pharmaceutical Quality Management Systems
Table 4 GMP Regulations
Table 5 Pharmaceutical Quality Management Software: Pricing
Table 6 Global Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 7 Global Non-Conformance/Deviation Management Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Document Management Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global CAPA Management Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Risk & Compliance Management Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Inspection Management Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Audit Management Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Suppliers & Materials Management Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Training Management Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Change Management Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Other Solution Types Market, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 18 Global Cloud/Web-Based Pharmaceutical Quality Management Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Global On-Premise Pharmaceutical Quality Management Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 21 Global Pharmaceutical Quality Management Systems Market for Pharmaceutical and Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Pharmaceutical Quality Management Systems Market For CDMO/CRO, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Pharmaceutical Quality Management Systems Market for Research Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Pharmaceutical Quality Management Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 25 North America: Pharmaceutical Quality Management Systems Market, by Country, 2022–2031 (USD Million)
Table 26 North America: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 27 North America: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 28 North America: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 29 U.S.: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 30 U.S.: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 31 U.S.: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 32 Canada: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 33 Canada: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 34 Canada: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 35 Europe: Pharmaceutical Quality Management Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 36 Europe: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 37 Europe: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 38 Europe: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 39 Germany: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 40 Germany: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 41 Germany: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 42 France: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 43 France: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 44 France: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 45 U.K.: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 46 U.K.: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 47 U.K.: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 48 Italy: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 49 Italy: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 50 Italy: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 51 Spain: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 52 Spain: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 53 Spain: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 54 Ireland: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 55 Ireland: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 56 Ireland: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 57 Belgium: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 58 Belgium: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 59 Belgium: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 60 Netherlands: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 61 Netherlands: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 62 Netherlands: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 63 Rest of Europe: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 64 Rest of Europe: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 65 Rest of Europe: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 66 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 67 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 68 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 69 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 70 China: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 71 China: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 72 China: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 73 Japan: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 74 Japan: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 75 Japan: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 76 India: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 77 India: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 78 India: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 79 Singapore: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 80 Singapore: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 81 Singapore: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 82 Malaysia: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 83 Malaysia: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 84 Malaysia: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 85 Philippines: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 86 Philippines: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 87 Philippines: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 88 Vietnam: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 89 Vietnam: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 90 Vietnam: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 91 Rest of Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 92 Rest of Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 93 Rest of Asia-Pacific: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 94 Latin America: Pharmaceutical Quality Management Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 95 Latin America: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 96 Latin America: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 97 Latin America: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 98 Brazil: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 99 Brazil: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 100 Brazil: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 101 Mexico: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 102 Mexico: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 103 Mexico: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 104 Rest of Latin America: Regulatory Agencies for Pharmaceutical Quality Management Systems
Table 105 Rest of Latin America: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 106 Rest of Latin America: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 107 Rest of Latin America: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 108 Middle East & Africa: Pharmaceutical Quality Management Systems Market, by Solution Type, 2022–2031 (USD Million)
Table 109 Middle East & Africa: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2022–2031 (USD Million)
Table 110 Middle East & Africa: Pharmaceutical Quality Management Systems Market, by End User, 2022–2031 (USD Million)
Table 111 Recent Developments, by Company, 2021–2024
Table 112 Pharmaceutical Quality Management Systems Market: Competitive Benchmarking by Solution
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referred for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Applications of QMS In the Pharmaceutical Industry
Figure 8 Global Pharmaceutical Quality Management Systems Market, by Solution Type, 2024 Vs. 2031 (USD Million)
Figure 9 Global Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2024 Vs. 2031 (USD Million)
Figure 10 Global Pharmaceutical Quality Management Systems Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 11 Global Pharmaceutical Quality Management Systems Market, by Geography
Figure 12 Impact Analysis of Market Dynamics
Figure 13 Global Pharmaceutical R&D Expenditure, 2012–2026 (USD Billion)
Figure 14 Global Increase in The Number of Personalized Medicines, 2008–2020
Figure 15 Advantages of Integrating AI into Pharmaceutical QMS
Figure 16 Global Pharmaceutical Quality Management Systems Market, by Solution Type, 2024 Vs. 2031 (USD Million)
Figure 17 Global Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2024 Vs. 2031 (USD Million)
Figure 18 Global Pharmaceutical Quality Management Systems Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 19 Global Pharmaceutical R&D Expenditure (2016–2024)
Figure 20 Global Pharmaceutical Quality Management Systems Market Assessment, by Country/Region, 2024 Vs. 2031 (USD Million)
Figure 21 North America: Pharmaceutical Quality Management Systems Market Snapshot
Figure 22 Europe: Pharmaceutical Quality Management Systems Market Snapshot
Figure 23 Asia-Pacific: Pharmaceutical Quality Management Systems Market Snapshot
Figure 24 India's Drug & Pharmaceutical Export Trend, 2017–2022
Figure 25 Clinical Trial Activities in Malaysia, 2015-2025
Figure 26 Latin America: Pharmaceutical Quality Management Systems Market Snapshot
Figure 27 Key Growth Strategies Adopted by Leading Players (2021-2024)
Figure 28 Pharmaceutical Quality Management Systems Market: Competitive Benchmarking, by Region
Figure 29 Competitive Dashboard: Pharmaceutical Quality Management Systems Market
Figure 30 Global Pharmaceutical Quality Management Systems Market Ranking Analysis, by Key Players (2023)
Figure 31 Honeywell International Inc.: Financial Overview (2023)
Figure 32 IQVIA Holding Inc.: Financial Overview (2023)
Figure 33 Dassault Systèmes SE: Financial Overview (2023)
Figure 34 Körber AG: Financial Overview (2023)
Figure 35 ANTARES VISION S.P.A.: Financial Overview (2023)
Figure 36 Hexagon AB: Financial Overview (2023)
Figure 37 Ideagen PLC: Financial Overview (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
